Efficacy of intramuscular injections of biotin and dexpanthenol in the treatment of diffuse hair loss: A randomized, double‐blind controlled study comparing two brands

Aniseh Samadi,Yasaman Ketabi,Rojin Firooz,Alireza Firooz

DOI: https://doi.org/10.1111/dth.15695

2022-07-06

Dermatologic Therapy

Abstract:Background & aim Combination therapy with biotin and dexpanthenol is a well‐known practice in preventing and treating hair loss, however, it's not well studied. In this study, we compared the efficacy of the six‐week treatment with two brands of biotin and dexpanthenol for the treatment of diffuse hair loss. Method Fifty eligible patients with diffused pattern hair loss, (41 women and 9 men) were randomized in a 1:1 ratio to receive either 6 weekly injections of dexpanthenol ampoule 250mg/2ml and biotin ampoule 5 mg/1ml, manufactured by Pars Behvarzan or Bayer Company. Combing test, Standard scalp photography and trichoscan assessment were performed before the first treatment session and one and eight weeks after the last one. Patients' satisfaction and drug adverse reactions were also recorded. Results One week and eight weeks after the last treatment session, hair fall count and total hair density significantly improved in both groups (p‐value<0.01 for hair fall count and 0.04 and 0.02, for hair density in Pars and Bayer groups respectively). There was no significant difference between the two groups in any other trichoscan parameter, except for improvement in terminal/vellus hair ratio in the Bayer group in both follow up visits, compared to the Pars group (p‐value = 0.02 and 0.033 for weeks one and eight). Conclusion Six‐ week treatment with both brands of biotin and dexpanthenol was effective and safe in people with diffused pattern hair loss This article is protected by copyright. All rights reserved.

dermatology